GROUP ONE TRADING, L.P. - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 82 filers reported holding OVID THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,0000.0%1,532
-2.3%
0.00%
Q2 2022$3,000
-70.0%
1,568
-48.9%
0.00%
Q1 2022$10,000
-75.6%
3,068
-76.2%
0.00%
Q4 2021$41,000
-77.5%
12,906
-76.2%
0.00%
Q3 2021$182,000
-29.2%
54,307
-17.3%
0.00%
Q2 2021$257,000
-61.6%
65,701
-60.5%
0.00%
-100.0%
Q1 2021$669,000
+340.1%
166,356
+153.5%
0.00%
Q4 2020$152,00065,635
+105762.9%
0.00%
Q3 2020$0
-100.0%
62
-99.3%
0.00%
Q2 2020$62,0008,4000.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$407,0000.69%
BVF INC/IL 3,293,000$5,829,0000.65%
COWEN INC. 1,101,414$1,950,0000.21%
ARMISTICE CAPITAL, LLC 1,780,000$3,151,0000.17%
Granite Point Capital Management, L.P. 417,857$740,0000.07%
Redmile Group, LLC 737,550$1,305,0000.04%
Tekla Capital Management LLC 496,977$880,0000.04%
Fairpointe Capital LLC 101,000$179,0000.01%
Alyeska Investment Group, L.P. 225,000$398,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,440$149,0000.00%
View complete list of OVID THERAPEUTICS INC shareholders